Legal & General Group
CARL

Legal & General Group’s Carlsmed CARL Stock Holding History

Legal & General Group’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26K Sell
579
-78
-12% -$943 ﹤0.01% 3280
2025
Q4 		$8.09K Hold
657
– – ﹤0.01% 3287
2025
Q3 		$8.82K Buy
+657
New +$8.98K ﹤0.01% 3313

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's CARL Position: Q1 2026 in Review

Legal & General Group reduced its Carlsmed (CARL) stake by 12% in Q1 2026, selling an estimated $943 and leaving 579 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3280.

Legal & General Group first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.82K in Q3 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Legal & General Group held 579 shares of Carlsmed worth $5.26K as of Q1 2026.
  • Legal & General Group sold 78 Carlsmed shares in Q1 2026, an estimated $943.
  • Carlsmed made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3280 holding.
  • Legal & General Group first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • Legal & General Group's Carlsmed position peaked at $8.82K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.